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THE ROLE OF TRANSFORMING GROWTH FACTOR ALPHA
IN A MOUSE MODEL OF OSTEOARTHRITIS
S.E. Usmani, C.T. Appleton, I.D. Welch, F. Beier
The Univ. of Western Ontario, London, ON, Canada
Purpose: Osteoarthritis (OA) affects approximately ten percent
of all Canadians and is the leading cause of physical disability
and impaired quality of life in North America. Despite the preva-
lence and severity of this degenerative joint disease, its underlying
pathological mechanisms are not well understood. Recently, our
lab established a surgical rodent model of OA in order to study
gene expression changes in degenerating articular cartilage. We
found that transforming growth factor alpha (TGF alpha) gene
expression was upregulated in our model, and thus identiﬁed
TGF alpha as a novel growth factor involved in OA. Further in vitro
studies showed that TGF alpha treatment suppressed chondrocyte
expression of the anabolic factors aggrecan and type II collagen
and increased expression of the catabolic factor matrix metallo-
proteinase 13 (MMP13). The purpose of this study is to examine
the requirement for TGF alpha in the progression of osteoarthritis
in vivo. We hypothesize that Tgfa null mice will experience de-
layed OA progression compared to control littermates in a surgical
disease model.
Methods: Ten week old Tgfa null mice and their heterozygous
littermates underwent meniscotibial transaction (MTX) of the left
knee joint in order to create a mild form of degenerative disease.
Mice from both groups also received sham surgery (capsulec-
tomy). Seven weeks post-surgery, animals were sacriﬁced, and
their knee joints were isolated and prepared for histology. Tissues
were stained with safranin-O/fast green and joint histopathology
was scored using the Osteoarthritis Research Society International
(OARSI) criteria. Tissues were also immunostained for MMP13 ex-
pression.
Results: Preliminary results show that MTX appears to produce
a very mild form of degenerative joint disease while sham surgery
shows no sign of disease at seven weeks-post surgery. Impor-
tantly, Tgfa null mice have lower OARSI scores and express less
MMP13 than their heterozygous littermates at this time point.
Conclusions: TGF alpha appears to play an important role in the
progression of osteoarthritis in vivo. Future studies will examine
the expression of additional anabolic and catabolic factors in Tgfa
null joints as well as the potential role of TGF alpha in the cartilage
growth plate.
087
IMPLEMENTATION OF A SCID ENGRAFTMENT MODEL
WITH SYNOVIAL FIBROBLASTS AND CARTILAGE TO
CHARACTERIZE OA PATIENTS
L.M. Gierman1, A. Koudijs1, M. Kloppenburg2,
V. Stojanovic-Susulic3, G.J. Van Osch4, T.W. Huizinga2,
A.-M. Zuurmond1
1TNO, Leiden, Netherlands; 2LUMC, Leiden, Netherlands;
3Centocor, Radnor, PA; 4Erasmus MC, Rotterdam, Netherlands
Purpose: Patient heterogeneity is probably one of the reasons for
failure of osteoarthritis (OA) clinical trials. We aim at identifying
novel biomarkers and disease mechanism by focussing on adi-
pose and synovial tissue from OA patients for improved patient
stratiﬁcation
Methods: For this purpose, we implemented an engraftment
model in the SCID mouse for in vivo characterization of synovial
and adipose tissue from OA patients. The model was set up using
synovial ﬁbroblasts from rheumatoid arthritis (RA) patients that are
known for their invasive behaviour. A sterile gelfoam sponge was
seeded with synovial ﬁbroblasts and co-implanted together with
bovine cartilage. Evaluation of cartilage destruction and synovio-
cyte invasion was performed 60 days after implantation by H&E
and safranine-O staining and compared with cartilage implanted
with synovial ﬁbroblasts from healthy donors.
Results: Cartilage destruction and invasion of RA synovial ﬁbrob-
last in the cartilage was observed.
Conclusions: This model will be used to study the effects of
adipose and synovial tissue from OA patients on cartilage integrity
and invasive behaviour
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A STATISTICAL MODELING APPROACH OF THE
RELATIONSHIPS BETWEEN SPECIFIC TISSUE LESIONS
AND FUNCTIONAL DISABILITY IN EXPERIMENTAL CANINE
OSTEOARTHRITIS
J.R. del Castillo1, M. Moreau1,2, M.-A. D’Anjou2, J.-P. Pelletier3,
J. Martel-Pelletier3, C. Boileau3, F. Abram4, J.-P. Raynauld3,
E. Troncy1
1GREPAQ - Fac. vet. med. - Université de Montréal, St-Hyacinthe,
QC, Canada; 2GRAC - Fac. vet. med. - Université de Montréal,
St-Hyacinthe, QC, Canada; 3Osteoarthritis Res. Unit -
Notre-Dame Hosp., CR-CHUM - Université de Montréal, Montréal,
QC, Canada; 4ArthroVision Inc., Montréal, QC, Canada
Purpose: Pain, morphological alterations and functional disabil-
ity are cardinal features of the osteoarthritic (OA) joint. However,
the relationship of joint structural damages to functional limb
impairment remains to be clariﬁed. This study aimed at investi-
gating in an experimental canine anterior/cranial cruciate ligament
(ACL)-induced instability model, the time-course of the relationship
between some variables monitored with podobarometric gait anal-
ysis and the joint structural damages using magnetic resonance
imaging (MRI).
Methods: OA was surgically induced by transection of the right
ACL in ﬁve dogs, which were subject to concurrent podobarometric
gait analysis and MRI examinations prior to surgery (baseline), as
well as 4, 8, and 26 weeks afterwards. The peak vertical force
(PVF) and ground contact area (GCA) were measured, and ordinal
scales were used to grade the cartilage defects, joint effusion, and
osteophytosis found at MRI, as well as the subchondral bone
marrow lesions (BML) assessed on T1GRE, T2wFS, and SPGR
sequences. Changes in cartilage volume were quantiﬁed from
computerized reconstruction. A mixed-effect general linear model
for repeated measures with ﬁrst-order autoregressive covariance
structures was built for testing global mobility with ln (PVF), and
a second one for testing gait changes with GCA. Time, the MRI
variables, and selected dual interactions were added sequentially
as ﬁxed effects in both models, and GCA was an additional
ﬁxed-effect predictor of ln_(PVF). Both models were solved with
maximum likelihood estimation at the 0,05 α-level.
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Results: Following ACL section, limb impairment rapidly devel-
oped in all dogs, with PVF and GCA values dropping by week
4. After this acute disability phase, the dogs underwent a slow
remission phase that was still incomplete by week 26. Prediction
of PVF change was best estimated (R2=0.96) from GCA and BML-
SPGR (p<0.0001), particularly during the phase of acute disability,
whereas cartilage defect was more inﬂuential (R2=0.97) during the
remission phase (p=0.0051) (week 8 to week 26). The other joint
structural damages had insigniﬁcant effect on limb impairment and
recovery. Both BML-SPGR and cartilage defect adversely affected
the recovery in PVF, with mutually independent effects.
Similar to ln_PVF, GCA showed an acute drop by week 4, followed
afterwards by a remission phase (p<0.0001), which attained base-
line values by week 26 (p=0,46). The time-course of GCA recovery
was negatively affected by cartilage defect, and was positively af-
fected by joint effusion (p<0.0001 for both variables).
Conclusions: In recent human OA studies, pain and limb im-
pairment were related mostly to BML and joint effusion. Our data
from dogs with experimental OA conﬁrms the role of BML and
joint effusion on limb function. On one hand, BML and carti-
lage defect hinder the recovery of PVF. On the other hand, joint
effusion positively inﬂuences GCA, supporting the existence of
alleviating mechanisms that oppose to abnormal biomechanics.
This study also clariﬁes the role of cartilage and other joint struc-
tural components in OA: cartilage volume and osteophytosis act
as confounding factors with negligible role in limb impairment.
Such structure/function modeling opens promising avenues for as-
sessing outcome of disease-modifying OA drugs at the preclinical
development stage.
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SELECTIVE AGGRECANASE INHIBITION IS DISEASE
MODIFYING AND PAIN ALLEVIATING IN A RAT MENISCAL
TEAR MODEL OF OSTEOARTHRITIS
S.S. Glasson1, A. Bendele2, P.-E. Sum1, S. Tam1, J. Tejada1,
M. Rivera-Bermudez1, J. Skotnicki3, E. Morris1, K. Georgiadis1
1Wyeth, Cambridge, MA; 2Bolder BioPath, Boulder, CO; 3Wyeth,
Pearl River, NY
Purpose: The purpose of the study was to evaluate the efﬁcacy
of an ADAMTS-4 and ADAMTS-5 selective inhibitor in a robust
animal model of osteoarthritis (OA).
Methods: All animal studies were performed after IACUC ap-
proval. Male Lewis rats (20 per group) underwent medial meniscal
tear surgery in the right knee joint1. Rats were treated twice daily
by oral gavage with vehicle, selective ADAMTS-4/-5 inhibitor (ASI)
(10, 30, or 100 mg/kg) or a broad-spectrum MMP inhibitor (30
mg/kg), All treatments were initiated 1 day before surgery and
continued for 13 weeks. At the end of the dosing period, rats
were evaluated for normal mobility and plasma was taken for
pharmacokinetic analysis. Weight-bearing on the operated right
leg and contra-lateral left leg was evaluated in the vehicle-treated
and 30 mg/kg ASI-treated groups using an incapacitance meter,
and expressed as grams difference in weight bearing between
right and left leg. Following euthanasia, right knees were collected
for histopathology evaluation including subjective and objective
measures of cartilage degeneration and measures of joint capsule
thickening.
Results: Statistically signiﬁcant decreases in cartilage degenera-
tion scores and width of severe lesions were observed in animals
treated with both 30 and 100 mg/kg BID ASI. No adverse events
were observed in animals treated with any dose of ASI. Broad-
spectrum MMP inhibitor treatment resulted in decreased histologic
evidence of cartilage degradation, but also caused a 40% thick-
ening of the medial joint capsule, 6% lower body weight and a
reluctance to mobilize. The vehicle-treated animals demonstrated
a 27±2 grams decrease in weight bearing on the operated com-
pared to the control limb, while the animals treated with 30 mg/kg
SI had only a 16±2 grams decrease in weight bearing. This 41%
increase in relative weight bearing on the unstable knee was
statistically signiﬁcant.
Conclusions: This study demonstrated that the signiﬁcant reduc-
tion in cartilage degradation following surgical induction of joint
instability observed in gene-deleted ADAMTS-5 and ADAMTS-4/5
mice can also be produced by small molecule inhibition of en-
zyme activity. There were no adverse physiologic effects following
systemic inhibition of ADAMTS-4/5 activity for 13 weeks. The nor-
malization of weight-bearing, after treatment with an efﬁcacious
dose of ASI, indicated that decreasing cartilage degradation as
a result of inhibition of Aggrecanase-mediated aggrecan degra-
dation, positively affected stance and pain. These results support
this strategy of selective ADAMTS-4/5 inhibition as a safe and
effective method of disease modiﬁcation and pain modiﬁcation of
osteoarthritis, and should be evaluated in the clinic.
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GAIT ANALYSIS AND BEHAVIOURAL PAIN RESPONSE OF
TWO RODENT MODELS OF OSTEOARTHRITIS
C.E. Ferland, S. Laverty, F. Beaudry, P. Vachon
Faculté de Médecine Vétérinaire, Université de Montréal,
Saint-Hyacinthe, QC, Canada
Purpose: To evaluate gait pattern recorded on the CatWalk and
pain behaviour in two different rat models of osteoarthritis (OA).
Methods: Twenty-two male Sprague-Dawley rats weighing
200±25g were studied. Two weeks prior to the induction of OA,
animals were trained on the CatWalk runway (Noldus) to traverse
the corridor uninterruptedly. Mechanical allodynia was assessed
by measurement of withdrawal thresholds in response to appli-
cation of von Frey ﬁlaments. During the second week of the
training period, data were collected to obtain baseline values.
One group of rats (n=8) underwent surgical anterior cruciate liga-
ment transection with partial medial menisectomy (ACLT+pMMx)
to mimic a joint instability model and another (n=8) received an
intra-articular injection of monoiodoacetate (MIA) (3mg/30μl) as
an inﬂammatory pain model. After recuperation (2 days MIA, 5
days ACLT+pMMx), the tests were performed for four consecu-
tive weeks. After the behavioural measurement period, rats were
sacriﬁced. Both knee joints were collected for histological assess-
ment as well as spinal cord lumbar enlargements for neuropeptide
analysis by HPLC/ESI/MS/MS. Repeated measure analysis of
variances (linear model) followed by a sequential Bonferonni cor-
rection were performed for gait analysis parameters and von Frey
results.
Results: No signiﬁcant differences were observed in the gait
speed between the three groups at each time point and in com-
parison with the baseline values. Changes in dynamic gait pa-
rameters were observed starting on the ﬁrst day of testing, post
OA-induction, in both models. A tendency towards stabilization
in the surgical model was observed with parameters returning
near to the baseline values (ex. swing phase duration, the swing
speed and the ratio between the stance phase and the com-
plete stepcycle duration). These observations were seen in both
hind limbs, with no statistical differences between the ipsilateral
and the contralateral limbs. Conversely, in the MIA model sig-
niﬁcant changes remained in the injured limb compared to the
contralateral limb in the swing phase duration (p<0.02) and the
swing speed (p0.2). With von Frey ﬁlaments, mechanical sensi-
tisation was observed in the ipsilateral limb of the MIA model
only (p<0.0001). Neuropeptide analysis demonstrated signiﬁcant
increase in CGRP concentrations in both models with 5803±1520
pmol/g and 4651±586pmol/g in the ACLT+pMMx and MIA models
